Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Royer

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
Journal of Mass Spectrometry : JMS|June 8, 2010
An APCI LC-MS/MS method for routine determination of capecitabine and its metabolites in human plasmaDamien Montange, Michel Bérard, Martin Demarchi, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 10, 2013
Immunomodulatory effects of everolimus in a long responsive patient with metastatic renal cell carcinomaAntoine Thiery-Vuillemin, Caroline Laheurte, Laura Mansi, et al.
Cancer Chemotherapy and Pharmacology|April 29, 2017
Hemodialysis does not impact axitinib exposure: clinical case of a patient with metastatic renal cell carcinomaAntoine Thiery-Vuillemin, Emeline Orillard, Guillaume Mouillet, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 8, 2009
Pharmacokinetics of mycophenolic acid administered 3 times daily after hematopoietic stem cell transplantation with reduced-intensity regimenBernard Royer, Fabrice Larosa, Faezeh Legrand, et al.
Molecular Therapy. Methods & Clinical Development|September 8, 2025
Beneficial effect of resveratrol on T cell oxidative metabolism and anti-tumor function is conditioned by prior <i>in vivo</i> T cell historyPatricia Mercier-Letondal, Chrystel Marton, Bernard Royer, et al.
World Journal of Surgical Oncology|February 8, 2012
High-pressure intrapleural chemotherapy: feasibility in the pig modelOlivier Facy, Pierre-Benoit Pages, Pablo Ortega-Deballon, et al.
Clinical Pharmacokinetics|September 12, 2009
Pharmacokinetic modelling and development of Bayesian estimators for therapeutic drug monitoring of mycophenolate mofetil in reduced-intensity haematopoietic stem cell transplantationFranck Saint-Marcoux, Bernard Royer, Jean Debord, et al.
Circulation|September 13, 2003
Mesenchymal progenitor cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a rat cellular cardiomyoplasty modelSiamak Davani, Aliette Marandin, Nursen Mersin, et al.
Endocrine Connections|December 12, 2018
Pharmacokinetic interaction between mitotane and etoposide in adrenal carcinoma: a pilot studyAnne Jouinot, Bernard Royer, Etienne Chatelut, et al.
Clinical Pharmacology and Therapeutics|November 22, 2022
Plasma Uracil as a DPD Phenotyping Test: Pre-Analytical Handling Matters!Fabienne Thomas, Manon Launay, Jérôme Guitton, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Journal of Mass Spectrometry : JMS|June 8, 2010
An APCI LC-MS/MS method for routine determination of capecitabine and its metabolites in human plasmaDamien Montange, Michel Bérard, Martin Demarchi, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 10, 2013
Immunomodulatory effects of everolimus in a long responsive patient with metastatic renal cell carcinomaAntoine Thiery-Vuillemin, Caroline Laheurte, Laura Mansi, et al.
Cancer Chemotherapy and Pharmacology|April 29, 2017
Hemodialysis does not impact axitinib exposure: clinical case of a patient with metastatic renal cell carcinomaAntoine Thiery-Vuillemin, Emeline Orillard, Guillaume Mouillet, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 8, 2009
Pharmacokinetics of mycophenolic acid administered 3 times daily after hematopoietic stem cell transplantation with reduced-intensity regimenBernard Royer, Fabrice Larosa, Faezeh Legrand, et al.
Molecular Therapy. Methods & Clinical Development|September 8, 2025
Beneficial effect of resveratrol on T cell oxidative metabolism and anti-tumor function is conditioned by prior <i>in vivo</i> T cell historyPatricia Mercier-Letondal, Chrystel Marton, Bernard Royer, et al.
World Journal of Surgical Oncology|February 8, 2012
High-pressure intrapleural chemotherapy: feasibility in the pig modelOlivier Facy, Pierre-Benoit Pages, Pablo Ortega-Deballon, et al.
Clinical Pharmacokinetics|September 12, 2009
Pharmacokinetic modelling and development of Bayesian estimators for therapeutic drug monitoring of mycophenolate mofetil in reduced-intensity haematopoietic stem cell transplantationFranck Saint-Marcoux, Bernard Royer, Jean Debord, et al.
Circulation|September 13, 2003
Mesenchymal progenitor cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a rat cellular cardiomyoplasty modelSiamak Davani, Aliette Marandin, Nursen Mersin, et al.
Endocrine Connections|December 12, 2018
Pharmacokinetic interaction between mitotane and etoposide in adrenal carcinoma: a pilot studyAnne Jouinot, Bernard Royer, Etienne Chatelut, et al.
Clinical Pharmacology and Therapeutics|November 22, 2022
Plasma Uracil as a DPD Phenotyping Test: Pre-Analytical Handling Matters!Fabienne Thomas, Manon Launay, Jérôme Guitton, et al.
Pageof 7